Connect with us
[ad_1] Nov. 7, 2022 – If you’re among the 92% or so of Americans yet to get a bivalent COVID-19 booster, here’s some news to consider. The Pfizer/BioNTech...
[ad_1] The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the...
[ad_1] The omicron sublineages named BQ.1 and BQ.1.1 continued to spread in the U.S. in the week through Oct. 29, accounting for 27.1% of new cases...
[ad_1] The Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that...
[ad_1] Pfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130...
[ad_1] The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S.,...
[ad_1] Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck...
[ad_1] About half of the American public has heard little or nothing about the new COVID-19 bivalent booster, a new survey by the Kaiser Family Foundation...